• Alison B Breland, Dana Carroll, Rachel Denlinger-Apte, RossJennifer CornacchioneJCWake Forest School of Medicine, Division of Public Health Sciences, Department of Social Sciences and Health Policy, Medical Center Boulevard, Winston-Salem, NC 27157, USA. Electronic address: jcornacc@wakehealth.edu., Claradina Soto, Cassidy White, Eric C Donny, Pebbles Fagan, Phillip Gardiner, Thomas Eissenberg, and Mignonne C Guy.
• Virginia Commonwealth University, Department of Psychology, Center for the Study of Tobacco Products, 100 W. Franklin St., Suite 200, Richmond, VA 23220, USA. Electronic address: abbrelan@vcu.edu.
• Prev Med. 2022 Dec 1; 165 (Pt B): 107117107117.

AbstractAlthough overall health in the United States (US) has improved dramatically during the past century, long-standing health inequities, particularly the unequal and unjust burden of tobacco-related disease and death among racialized populations, persist. A considerable gap exists in our understanding of how commercial tobacco product regulations and policies cause and/or exacerbate race-based health inequities among Black/African American (B/AA) and Indigenous American people. The purpose of this paper is to 1) describe how existing US commercial tobacco regulatory policies may contribute to structural racism and undermine the full benefits of tobacco prevention and control efforts among B/AA and Indigenous American groups; and 2) initiate a call to action for researchers and regulators of tobacco products to examine policies using an equity lens. These actions are imperative if empirically-informed regulation of commercial tobacco products is to address health equity.Copyright © 2022 Elsevier Inc. All rights reserved.

12 keywords...

hide…